Cintia Piccina
Corporate Officer/Principal chez ADAPTIMMUNE THERAPEUTICS PLC
Fortune : 175 231 $ au 30/04/2024
Profil
Cintia Piccina is currently the Chief Commercial Officer at Adaptimmune Therapeutics Plc.
She started this position in 2024.
Prior to her current role, she held the same position at Adaptimmune Therapeutics Plc from 2022 to 2023.
Cintia also has experience as the SVP-Commercial Oncology & US General Manager at 2seventy Bio, Inc. and as the Chief Commercial Officer at AlloVir, Inc. In terms of education, Dr. Piccina holds a doctorate degree from the University of Sao Paulo and an MBA from Escola Superior de Propaganda e Marketing.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALLOVIR INC
0,13% | 03/07/2023 | 147 000 ( 0,13% ) | 117 600 $ | 30/04/2024 |
| 01/04/2024 | 326 154 ( 0,06% ) | 57 631 $ | 30/04/2024 |
Postes actifs de Cintia Piccina
| Sociétés | Poste | Début |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 18/03/2024 |
Anciens postes connus de Cintia Piccina
| Sociétés | Poste | Fin |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 05/03/2023 |
| ALLOVIR, INC. | Corporate Officer/Principal | - |
| 2SEVENTY BIO, INC. | Corporate Officer/Principal | - |
Formation de Cintia Piccina
| University of Sao Paulo | Doctorate Degree |
| Escola Superior de Propaganda e Marketing | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| 2SEVENTY BIO, INC. | Health Technology |
| ALLOVIR, INC. | Health Technology |
